Thalassaemia: the dental implications of bisphosphonate therapy

Bisphosphonates (BP) are commonly used in individuals with thalassaemia to stabilise bone remodelling. However, in recent years, evidence has emerged that bisphosphonate related osteonecrosis of the jaw (BONJ) may occur. Cases of BONJ have recently been confirmed in individuals with thalassaemia. Th...

Full description

Bibliographic Details
Main Author:	Navdeep Kumar
Format:	Article
Language:	English
Published:	PAGEPress Publications 2014-12-01
Series:	Thalassemia Reports
Subjects:	bisphosphonates thalassaemia bisphosphonate related osteonecrosis of the jaw BONJ.
Online Access:	http://www.pagepressjournals.org/index.php/thal/article/view/4872

id	doaj-2ffa4143764f49a1883b58f15245846d
record_format	Article
spelling	doaj-2ffa4143764f49a1883b58f15245846d2020-11-25T03:45:06ZengPAGEPress PublicationsThalassemia Reports2039-43572039-43652014-12-014310.4081/thal.2014.48723988Thalassaemia: the dental implications of bisphosphonate therapyNavdeep Kumar0Eastman Dental Hospital, LondonBisphosphonates (BP) are commonly used in individuals with thalassaemia to stabilise bone remodelling. However, in recent years, evidence has emerged that bisphosphonate related osteonecrosis of the jaw (BONJ) may occur. Cases of BONJ have recently been confirmed in individuals with thalassaemia. The aim of the presentation is to detail the prevalence of BONJ, outline the presentation (exposed vs non-exposed), describe the management strategies that have been proposed, and discuss some risk reduction strategies.http://www.pagepressjournals.org/index.php/thal/article/view/4872bisphosphonatesthalassaemiabisphosphonate related osteonecrosis of the jawBONJ.
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Navdeep Kumar
spellingShingle	Navdeep Kumar Thalassaemia: the dental implications of bisphosphonate therapy Thalassemia Reports bisphosphonates thalassaemia bisphosphonate related osteonecrosis of the jaw BONJ.
author_facet	Navdeep Kumar
author_sort	Navdeep Kumar
title	Thalassaemia: the dental implications of bisphosphonate therapy
title_short	Thalassaemia: the dental implications of bisphosphonate therapy
title_full	Thalassaemia: the dental implications of bisphosphonate therapy
title_fullStr	Thalassaemia: the dental implications of bisphosphonate therapy
title_full_unstemmed	Thalassaemia: the dental implications of bisphosphonate therapy
title_sort	thalassaemia: the dental implications of bisphosphonate therapy
publisher	PAGEPress Publications
series	Thalassemia Reports
issn	2039-4357 2039-4365
publishDate	2014-12-01
description	Bisphosphonates (BP) are commonly used in individuals with thalassaemia to stabilise bone remodelling. However, in recent years, evidence has emerged that bisphosphonate related osteonecrosis of the jaw (BONJ) may occur. Cases of BONJ have recently been confirmed in individuals with thalassaemia. The aim of the presentation is to detail the prevalence of BONJ, outline the presentation (exposed vs non-exposed), describe the management strategies that have been proposed, and discuss some risk reduction strategies.
topic	bisphosphonates thalassaemia bisphosphonate related osteonecrosis of the jaw BONJ.
url	http://www.pagepressjournals.org/index.php/thal/article/view/4872
work_keys_str_mv	AT navdeepkumar thalassaemiathedentalimplicationsofbisphosphonatetherapy
_version_	1724511373000441856

Thalassaemia: the dental implications of bisphosphonate therapy

Similar Items